Javascript must be enabled to continue!
P1415Wide antral circumferential pulmonary vein isolation ablation using a novel balloon cryoablation catheter
View through CrossRef
Abstract
Background
Pulmonary vein isolation using cryotherapy is an established treatment for the management of patients with paroxysmal atrial fibrillation. Ablation using the commercially available balloon cryocatheter has been shown to create wide antral pulmonary vein isolation. A novel balloon cryocatheter (BCC) has been designed to maintain uniform pressure and size during ablation, potentially improving contact with the antral anatomy. The extent of ablation created using the novel BCC has not previously been established.
Purpose
To determine the anatomical extent of pulmonary vein isolation using electroanatomical mapping when performing catheter ablation for paroxysmal atrial fibrillation using the novel BCC.
Methods
Nine consecutive patients underwent pre-procedure computed tomography angiography of the left atrium to quantify the chamber dimensions. An electroanatomical map was created using the cryoablation system mapping catheter and a high definition mapping system. A bipolar voltage map was obtained following ablation to determine the extent of pulmonary vein isolation ablation. A volumetric technique was used to quantify the extent of vein and posterior wall electrical isolation in addition to traditional techniques for proving entrance and exit block.
Results
All patients had paroxysmal atrial fibrillation, mean age 56 years, 7 (78%) male. Electrical isolation was achieved for 100% of the pulmonary veins; mean total procedure time was 109 min (+/- 26 SD), and fluoroscopy time 14.9 min (+/- 2.4 SD). The median treatment applications per vein was one (range one - four), and median treatment duration 180 sec (range 180 -240). Left atrial volume 32 mL/m2 (+/- 7 SD), and mean left atrial posterior wall area 22 cm2 (+/- 4 SD). Data was available for quantitative assessment of the extent of ablation for eight patients. No lesions (0 of 32) were ostial in nature. The antral surface area of ablation was not statistically different between the left and right sided pulmonary veins (p 0.63), which were 5.9 (1.6 SD) and 5.4 (2.1 SD) cm2 respectively. In total 50% of the posterior left atrial wall was ablated.
Conclusion
Pulmonary vein isolation using a novel BCC provides a wide and antral lesion set. There is significant debulking of the posterior wall of the left atrium.
Abstract Figure.
Title: P1415Wide antral circumferential pulmonary vein isolation ablation using a novel balloon cryoablation catheter
Description:
Abstract
Background
Pulmonary vein isolation using cryotherapy is an established treatment for the management of patients with paroxysmal atrial fibrillation.
Ablation using the commercially available balloon cryocatheter has been shown to create wide antral pulmonary vein isolation.
A novel balloon cryocatheter (BCC) has been designed to maintain uniform pressure and size during ablation, potentially improving contact with the antral anatomy.
The extent of ablation created using the novel BCC has not previously been established.
Purpose
To determine the anatomical extent of pulmonary vein isolation using electroanatomical mapping when performing catheter ablation for paroxysmal atrial fibrillation using the novel BCC.
Methods
Nine consecutive patients underwent pre-procedure computed tomography angiography of the left atrium to quantify the chamber dimensions.
An electroanatomical map was created using the cryoablation system mapping catheter and a high definition mapping system.
A bipolar voltage map was obtained following ablation to determine the extent of pulmonary vein isolation ablation.
A volumetric technique was used to quantify the extent of vein and posterior wall electrical isolation in addition to traditional techniques for proving entrance and exit block.
Results
All patients had paroxysmal atrial fibrillation, mean age 56 years, 7 (78%) male.
Electrical isolation was achieved for 100% of the pulmonary veins; mean total procedure time was 109 min (+/- 26 SD), and fluoroscopy time 14.
9 min (+/- 2.
4 SD).
The median treatment applications per vein was one (range one - four), and median treatment duration 180 sec (range 180 -240).
Left atrial volume 32 mL/m2 (+/- 7 SD), and mean left atrial posterior wall area 22 cm2 (+/- 4 SD).
Data was available for quantitative assessment of the extent of ablation for eight patients.
No lesions (0 of 32) were ostial in nature.
The antral surface area of ablation was not statistically different between the left and right sided pulmonary veins (p 0.
63), which were 5.
9 (1.
6 SD) and 5.
4 (2.
1 SD) cm2 respectively.
In total 50% of the posterior left atrial wall was ablated.
Conclusion
Pulmonary vein isolation using a novel BCC provides a wide and antral lesion set.
There is significant debulking of the posterior wall of the left atrium.
Abstract Figure.
Related Results
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
<div>AbstractPurpose:<p>Cryoablation is a minimally invasive procedure implemented to destroy solid tumors. It also results in the release of tumor antigens into the sy...
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
<div>AbstractPurpose:<p>Cryoablation is a minimally invasive procedure implemented to destroy solid tumors. It also results in the release of tumor antigens into the sy...
1692 Retrieval of Impacted Extraction Balloon: A Rare Complication of ERCP for Choledocholithiasis
1692 Retrieval of Impacted Extraction Balloon: A Rare Complication of ERCP for Choledocholithiasis
INTRODUCTION:
ERCP is an essential tool in the management of biliary disorders. A large variety of rare ERCP related complications have been reported such as an impacti...
THE INFLUENCE OF PULMONARY VEIN ANATOMY ON OUTCOMES AFTER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION
THE INFLUENCE OF PULMONARY VEIN ANATOMY ON OUTCOMES AFTER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION
Background. Pulmonary vein isolation is the cornerstone of catheter-based treatment for atrial fibrillation. Cryoballoon ablation offers an effective and reproducible method for pu...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Short term biatrial remodeling after pulsed field ablation vs cryoablation: a comparative cardiac magnetic resonance volumetric and strain analysis
Short term biatrial remodeling after pulsed field ablation vs cryoablation: a comparative cardiac magnetic resonance volumetric and strain analysis
Abstract
Background
Pulsed field ablation (PFA) is emerging as a non-thermal modality for Pulmonary vein isolation (PVI) ...
Abstract 3226: The “Single-Big-Cryo-Balloon” Technique for Pulmonary Vein Isolation - A New Ice Age?
Abstract 3226: The “Single-Big-Cryo-Balloon” Technique for Pulmonary Vein Isolation - A New Ice Age?
Background: Cryothermal-energy (CTE) applied via a balloon catheter (Arctic Front, Cryocath) represents a novel technology which may facilitate accomplishing the challenging endpoi...
Insights into level of pulmonary vein isolation using pulsed-field ablation for atrial fibrillation and unexpected effects in the posterior wall
Insights into level of pulmonary vein isolation using pulsed-field ablation for atrial fibrillation and unexpected effects in the posterior wall
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background/In...

